Senior insider sale
Chief Scientific Officer at EQUILLIUM, INC. — senior position signals high conviction
$632.8K
200K shares
What this filing means
CONNELLY STEPHEN plans to sell 200K shares of EQUILLIUM, INC. valued at approximately $632.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001974158-26-000071
DirectorOfficer· Chief Scientific Officer
Since Oct 2018
200K
Shares to sell
$632.8K
Approx. market value
200K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders shares acquired at incorporation
N/A
5/27/2017
200KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/27/2017 | Founders shares acquired at incorporation N/A | 200K | — |
| Total | 200K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
200K
Market value
$632.8K
6/4/2026
Total
Units
200K
Value
$632.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/4/2026 | 200K | $632.8K | NASDAQ | Planned |
| Total | 200K | $632.8K | ||